admin 
Gabriel Paijo 
Hendra Lukman 
George Ongkojoyo Magnesium Emerges as a Crucial Regulator of Vitamin D Levels, Potentially Resolving Long-Standing Health Debates
Researchers at the Vanderbilt-Ingram Cancer Center have unveiled groundbreaking findings that illuminate the intricate relationship...
Experimental Cancer Drug Navitoclax Shows Potential to Revolutionize Tuberculosis Treatment and Mitigate Long-Term Lung Damage
In a significant breakthrough for global infectious disease research, investigators at Johns Hopkins Medicine have...
Creative Resilience and Medical Innovation Ten-Year-Old Valerie’s Journey Through Hodgkin Lymphoma to the Glamorama Stage
In the bedroom of ten-year-old Valerie, a piece of custom artwork hangs as a definitive...
Osama Alsaleh Joins CureSearch Board of Directors to Accelerate Innovation in Pediatric Oncology Research
CureSearch for Children’s Cancer, a leading national nonprofit foundation dedicated to ending childhood cancer by...
NIH-Funded Research Teams Unveil Precision Gene Delivery Systems for Unprecedented Brain and Spinal Cord Cell Access
Nana O Research teams supported by the National Institutes of Health (NIH) have achieved a groundbreaking advancement...
A Decades-Old Protein, Erythropoietin, Unmasked as a Master Regulator of Cancer Immunity, Offering New Pathways for Immunotherapy Breakthroughs
Billy Candra Stanford University School of Medicine researchers have made a groundbreaking discovery, revealing that erythropoietin (EPO),...
Groundbreaking Research Unlocks Potential Immunotherapy Strategy for Rare, Aggressive Fibrolamellar Carcinoma Using Repurposed FDA-Approved Drug
Budi Oetomo Narendra A rare and aggressive form of liver cancer, fibrolamellar carcinoma (FLC), has long presented a...
Rethinking Tumour Genesis: Genetic Changes Alone Don’t Explain Tumour Growth in Neurofibromatosis Type 1
Gilang Cahya New research from leading institutions challenges decades of understanding regarding the development of tumours in...
Breakthrough Antibody Targeting SFRP2 Offers New Hope for Triple-Negative Breast Cancer Treatment and Immune Reprogramming
Triple-negative breast cancer (TNBC) remains one of the most formidable challenges in modern oncology, accounting...
Vitamin A Derivative Undermines Cancer Immunity, Paving Way for Novel Therapies
Researchers at the Princeton University Branch of the Ludwig Institute for Cancer Research have unveiled...
